AKT1 and obesity disorder: In addition, pro-inflammatory cytokine production and clinical symptoms in experimental autoimmune uveitis (EAU) were reduced through the inhibition of PI3K/AKT by a novel anti-angiogenic peptide H-RN, thus presenting another potential therapeutic option for attenuating obesity-associated inflammation (87).